Hasil Pencarian - V. Joachim Haupt

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.

    Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key. oleh V Joachim Haupt, Simone Daminelli, Michael Schroeder

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Correction: Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key.

    Correction: Drug Promiscuity in PDB: Protein Binding Site Similarity Is Key. oleh V. Joachim Haupt, Simone Daminelli, Michael Schroeder

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds

    An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds oleh Philipp Schake, Klevia Dishnica, Florian Kaiser, Christoph Leberecht, V. Joachim Haupt, Michael Schroeder

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor

    Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitor oleh Sarah Naomi Bolz, Sebastian Salentin, Gary Jennings, V. Joachim Haupt, Jared Sterneckert, Michael Schroeder

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Backbone Brackets and Arginine Tweezers delineate Class I and Class II aminoacyl tRNA synthetases.

    Backbone Brackets and Arginine Tweezers delineate Class I and Class II aminoacyl tRNA synthetases. oleh Florian Kaiser, Sebastian Bittrich, Sebastian Salentin, Christoph Leberecht, V Joachim Haupt, Sarah Krautwurst, Michael Schroeder, Dirk Labudde

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor.

    Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor. oleh Melissa F Adasme, Daniele Parisi, Kristien Van Belle, Sebastian Salentin, V Joachim Haupt, Gary S Jennings, Jörg-Christian Heinrich, Jean Herman, Ben Sprangers, Thierry Louat, Yves Moreau, Michael Schroeder

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling

    Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling oleh Alfredo Juárez-Saldivar, Michael Schroeder, Sebastian Salentin, V. Joachim Haupt, Emma Saavedra, Citlali Vázquez, Francisco Reyes-Espinosa, Verónica Herrera-Mayorga, Juan Carlos Villalobos-Rocha, Carlos A. García-Pérez, Nuria E. Campillo, Gildardo Rivera

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning

    Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning oleh Melissa F. Adasme, Sarah Naomi Bolz, Lauren Adelmann, Sebastian Salentin, V. Joachim Haupt, Adriana Moreno-Rodríguez, Benjamín Nogueda-Torres, Verónica Castillo-Campos, Lilián Yepez-Mulia, José A. De Fuentes-Vicente, Gildardo Rivera, Michael Schroeder

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: